Advertisement

Machine Learning Approach for Predicting New Uses of Existing Drugs and Evaluation of Their Reliabilities

Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1903)

Abstract

In this chapter, a new method to evaluate the reliability of predicting new uses of existing drugs was proposed. The prediction was performed with a support vector machine (SVM) using various data. Because the reliability of prediction could not be evaluated based on the output of an SVM, which was binary, the proposed method evaluated the reliability as a product of a distance from the separating hyperplane of the SVM and a similarity between the disease targeted by the drug and a candidate disease. A validation using real data revealed that the performance of the proposed method was promising.

Key words

Drug repositioning Machine learning Support vector machine (SVM) Side effect Chemical structure Drug target Reliability score 

Notes

Acknowledgments

The author thanks Mr. Kohei Adachi for his contribution toward an early version of this work.

References

  1. 1.
    Boguski MS, Mandl KD, Sukhatme VP (2009) Drug discovery. Repurposing with a difference. Science 324:1394–1395 PMID 19520944CrossRefGoogle Scholar
  2. 2.
    Chiang AP, Butte AJ (2009) Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clin Pharmacol Ther 86(PMID 19571805):507–510CrossRefGoogle Scholar
  3. 3.
    Yang L, Agarwal P (2011) Systematic drug repurposing based on clinical side-effects. PLoS One 6:e28025 PMID 22205936CrossRefGoogle Scholar
  4. 4.
    Cheng F, Liu C, Jiang J, Lu W, Li W, Liu G, Zhou W, Huang J, Tang Y (2012) Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol 8:e1002503 PMID 22589709CrossRefGoogle Scholar
  5. 5.
    Fukuoka Y, Takei D, Ogawa H (2013) A two-step drug repositioning method based on a protein-protein interaction network interaction network of genes shared by two diseases and the similarity of drugs. Bioinformation 9(PMID 23390352):89–93CrossRefGoogle Scholar
  6. 6.
    Wang Y, Chen S, Deng N, Wang Y (2013) Drug repositioning by kernel-based integration structure, molecular activity, and phenotype data. PLoS One 11:e78518 PMID 2424318CrossRefGoogle Scholar
  7. 7.
    Zhang P, Wang F, Hu J, Sorrentino R (2013) Exploring the relationship between drug side-effects and therapeutic indications. AMIA Annu Symp Proc:1568–1577 PMID 24551427Google Scholar
  8. 8.
    Adachi K, Fukuoka Y (2016) A method to predict new uses of existing drugs using machine learning and to evaluate their reliability. IEICE Tech Report MBE2015-102 (in Japanese)Google Scholar
  9. 9.
    Vapnik VN (1998) Statistical learning theory. Wiley, New YorkGoogle Scholar
  10. 10.
    Chen B, Wild D, Guha R (2009) PubChem as a source of polypharmacology. J Chem Inform Model 49:2044–2055 PMID 19708682CrossRefGoogle Scholar
  11. 11.
    Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P (2010) A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol 343(PMID 20087340):6Google Scholar
  12. 12.
    Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011) DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Res 39:D1035–D1041 PMID 21059682CrossRefGoogle Scholar
  13. 13.
    Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101(PMID 15075390):6062–6067CrossRefGoogle Scholar
  14. 14.
    Qin C, Zhang C, Zhu F, Xu F, Chen SY, Zhang P, Li YH, Yang SY, Wei YQ, Tao L, Chen YZ (2014) Therapeutic target database update 2014: a resource for targeted therapeutics. Nucleic Acids Res 42:D1118–D1123 [PMID 24265219]CrossRefGoogle Scholar
  15. 15.
    Yu W, Clyne M, Khoury MJ, Gwinn M (2010) Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associations. Bioinformatics 26:145–146 PMID 19864262CrossRefGoogle Scholar
  16. 16.
    Jaccard P (1912) The distribution of the flora in the alpine zone. New Phytol 11:37–50CrossRefGoogle Scholar
  17. 17.
    Dice LR (1945) Measures of the amount of ecologic association between species. Ecology 26:297–302CrossRefGoogle Scholar
  18. 18.
    Simpson EH (1949) Measurement of diversity. Nature 163:688CrossRefGoogle Scholar
  19. 19.
    Kimoto S (1967) Some quantitative analysis on the chrysomelid fauna of the Ryukyu archipelago. Esakia 6:27–54Google Scholar
  20. 20.
    Wall DP, Pivovarov R, Tong M, Jung JY, Fusaro VA, DeLuca TF, Tonellato PJ (2010) Genotator: a disease-agnostic tool for genetic annotation of disease. BMC Med Genet 3:50 PMID 21034472Google Scholar
  21. 21.
    Chang CC, Lin CJ (2011) LIBSVM: a library for support vector machines. ACM Trans Intel Sys Tech 2:1–27CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Kogakuin UniversityTokyoJapan

Personalised recommendations